Your browser doesn't support javascript.
loading
Efficacy of oral prolonged-release mesalazine in moderately active ulcerative colitis.
Paridaens, Kristine; Fullarton, John R; Travis, Simon P L.
Afiliación
  • Paridaens K; Medical Affairs Ferring International Center St-Prex Switzerland.
  • Fullarton JR; HEOR Violicom Medical Limited Aldermaston UK.
  • Travis SPL; NIHR Oxford Biomedical Research Centre Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital Oxford UK.
JGH Open ; 7(7): 516-519, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37496812
New meta-analyses are presented that provide further evidence supporting the effectiveness of oral prolonged-release mesalazine compared to other oral mesalazines as induction therapy in patients with moderately active ulcerative colitis.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JGH Open Año: 2023 Tipo del documento: Article Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JGH Open Año: 2023 Tipo del documento: Article Pais de publicación: Australia